ROCR Value Based Program Act

Reported lobbying issue

Medicare/Medicaid: S. 1261: CONNECT for Health Act- expands access to telehealth services under Medicare Medicare Physician Payment reforms: H. 879 - Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). Incentivizing the transition to value-based care including H.R. 786 - Preserving Patient Access to Accountable Care Act. Prior authorization reforms including H. 2433 - Reducing Medically Unnecessary Delays in Care Act and reintroduction of the Improving Seniors Timely Access to Care act. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. S. 705 - Innovation in Pediatric Drugs Act - to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations. Preserving the Medicaid Program for cancer patients. Health Issues: S. 864: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 1262: Give Kids a Chance Act - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Oncology Drug Shortages - Mitigate existing drug shortages and prevent future shortages of lifesaving and life-prolonging cancer drugs. HR 2484: Seniors' Access to Critical Medications Act - make permanent a waiver issued by the Centers for Medicare and Medicaid Services (CMS) that allowed for Medicare patients to receive critical medications by mail or allow for caregivers and family members to obtain medications for them. HR 2120/S 1031: ROCR Value Based Program Act - To amend title XVIII of the Social Security Act to create a Radiation Oncology Case Rate Value Based Payment Program exempt from budget neutrality adjustment requirements, and to amend section 1128A of title XI of the Social Security Act to create a new statutory exception for the provision of free or discounted transportation for radiation oncology patients to receive radiation therapy services. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. Tobacco: Support banning the sale of menthol cigarettes and flavored cigars Budget/Appropriations: FY 2025 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) and palliative care research. FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). House and Senate Budget Resolutions Indirect cost rate caps at the National Institutes of Health Proposed reorganizations and reductions in force at the Department of Health and Human Service

Reported lobbying issue

Health Issues: Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals. Medicare/Medicaid: H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals. Trade (domestic/foreign): Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade. Tariff (miscellaneous tariff bills): Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs. Budget/Appropriations: H.R. 8646 / H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027. Defense: H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.

Reported lobbying issue

Health Issues: Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Reported lobbying issue

Manufacturing: H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains Health Issues: H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (Support establishing an exception to medication step-therapy protocol in specified cases). Medicare/Medicaid: H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness Pharmacy: H.R. 3164, Ensuring Community Access to Pharmacist Services Act

Reported lobbying issue

Medicare/Medicaid: Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment. Health Issues: Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act. Budget/Appropriations: Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2027 Labor-HHS appropriations process. Veterans: Issues pertaining to veterans' access to proton therapy.

Reported lobbying issue

Health Issues: H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Issues related to support for independent physician practices, community pharmacies, and community-based care. Medicare/Medicaid: H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness. Pharmacy: H.R. 3164, Ensuring Community Access to Pharmacist Services Act Manufacturing: H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains

Reported lobbying issue

Environment/Superfund: EPA Rulemaking Restricting Ethylene Oxide (ETO) - Proposed rulemaking to place more-stringent limits on emissions and institute new monitoring requirements for ethylene oxide (ETO). Advocacy efforts include educating lawmakers on the importance of ETO in the sterilization of medical devices and potential shortages of sterile medical devices if EPA's proposed changes are enacted. Health Issues: Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communities Act - Advocacy for reauthorization of the SUPPORT Act, specifically for FDA approved alternative treatments for Chronic Pain, and medical devices role to address the opioid epidemic. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare. Veterans: Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system. Taxation/Internal Revenue Code: OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement. Trade (domestic/foreign): Supply Chain - advocacy efforts on topics that could potentially impact the medical device supply chain such as decisions made by the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party, outbound investments, raw materials, components, export controls, and shortage/supply chain resiliency reporting regulations. Submitted comments for the U.S. Dept of Commerce's investigation to determine the effects on the national security of imports of medical equipment including medical devices. Discussed the unique aspects and critical contributions of the U.S. medical technology sector as related to tariffs and other trade measures on imported medical devices and components and our support for policies that do not harm domestic manufacturing and global competition in the sector. Science/Technology: Issues related to the U.S. House discussion draft of the Great American AI Act (GAAIA) - Advocacy and education efforts on the importance of FDA retaining regulatory authority over AI used in medical devices, and on redundant or potentially harmful regulations that could impair patient access to devices or hinder innovation. Issues related to SECURE Data Act (H.R. 8413) - Advocacy for the inclusion of healthcare-related carveouts with exemptions for HIPAA covered entities and business associates, health records, and certain clinical research and patient-safety data. Also, advocacy for the inclusion of language preempting state frameworks by establishing a single federal standard. Manufacturing: Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.

Reported lobbying issue

Health Issues: FY2027 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Policy initiatives designed to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations Medicare/Medicaid: Oppose CMS's "efficiency adjustment" Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 2120 and S. 1031, a bill to modernize radiation oncology reimbursement - The Radiation Oncology Case Rate Value Based Program Act of 2025 Support for H.R. 879, to fix Medicare Physician Fee Schedule's physician payment reimbursement cuts Support H.R.3514, S.1816, the Improving Seniors' Timely Access to Care Act Support for H.R. 6160, Strengthening Medicare for Patients and Providers Act Homeland Security: U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC) Budget/Appropriations: Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for FY 2026 and FY2027 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding Support for report language encouraging NIH to support research into functional radiation medicine

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. H.R. 8163: Provider Reimbursement Stability Act, to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program. H.R. 8622: Medicare Physician Data-driven Performance Payment System Act to amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-driven Performance Payment System under the Medicare physician fee schedule H.R. 6160: Strengthening Medicare for Patients and Providers Act to modify certain adjustments to payment amounts under the Medicare physician fee schedule S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation. Health Issues: H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. H.R. 8339: Drug Origin Transparency Act to amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting H.R. 5526/S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521/S. 4440: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors. Budget/Appropriations: FY 2026 and FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP).

Reported lobbying issue

Medicare/Medicaid: Medicare Reimbursement and general Medicaid issues ROCR, H.R.1031 and S.2021 Health Issues: Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031 Cancer Care Trade (domestic/foreign): Trade issues between the U.S. and EU, US and China and U.S. - UK USMCA Tariff (miscellaneous tariff bills): Tariffs policies between US - EU, US - UK and US - China USMCA Energy/Nuclear: Nuclear Security issues, Nuclear Health issues, Cobalt 60 Gamma Knife Budget/Appropriations: Labor-HHS and AG-FDA appropriations bills

Reported lobbying issue

Veterans: Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Taxation/Internal Revenue Code: OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement. Health Issues: Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communities Act - Advocacy for reauthorization of the SUPPORT Act, specifically for FDA approved alternative treatments for Chronic Pain, and medical devices role to address the opioid epidemic. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare. Trade (domestic/foreign): Supply Chain - advocacy efforts on topics that could potentially impact the medical device supply chain such as decisions made by the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party, outbound investments, raw materials, components, export controls, and shortage/supply chain resiliency reporting regulations. Submitted comments for the U.S. Dept of Commerce's investigation to determine the effects on the national security of imports of medical equipment including medical devices. Discussed the unique aspects and critical contributions of the U.S. medical technology sector as related to tariffs and other trade measures on imported medical devices and components and our support for policies that do not harm domestic manufacturing and global competition in the sector. Environment/Superfund: EPA Rulemaking Restricting Ethylene Oxide (ETO) - Proposed rulemaking to place more-stringent limits on emissions and institute new monitoring requirements for ethylene oxide (ETO). Advocacy efforts include educating lawmakers on the importance of ETO in the sterilization of medical devices and potential shortages of sterile medical devices if EPA's proposed changes are enacted.

Reported lobbying issue

Health Issues: H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Medicare/Medicaid: H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness. Pharmacy: H.R. 3164, Ensuring Community Access to Pharmacist Services Act Manufacturing: H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains

Reported lobbying issue

Health Issues: H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors);S. 3822, Break Up Big Medicine Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Medicare/Medicaid: H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness Pharmacy: H.R. 3164, Ensuring Community Access to Pharmacist Services Act Manufacturing: H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains

Reported lobbying issue

Health Issues: Health care priorities of ACCC: a) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Inflation Reduction Act implementation, especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339); 8) Extension of Medicare reimbursement for telehealth services (passed in Feb. as part of the Consolidated Appropriations Act of 2026); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renew ACA subsidies and mitigate impact of Medicaid changes in OBBBA); 13) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 14) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Request to Designate April as Cancer Prevention and Early Detection month; 16) Modernize incentives for Advanced Alternative Payment Models (APMs); 17) Stabilize physician payment system and prepare for APMs; 18) Leverage the CMS Innovation Center; 19) Support Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; and 21) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization.

Reported lobbying issue

Budget/Appropriations: H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to Alternative Payment Models (APMs) H.R. 7148, Consolidated Appropriations Act, 2026, provisions related to APM bonus extension/incentive payments/qualifying provider revenue thresholds freeze H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, provisions relating to telehealth, Affordable Care Act (ACA) premium tax credits S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credits S. 3204, Preventive Health Savings Act, all provisions FY 2026 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill, provisions related to Stillbirth Working Groups funding H.R. 1197, PREEMIE Reauthorization Act of 2025, all provisions H.R. 1909, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions Womens health research funding/reproductive health/fertility treatments FY27 Gun Violence Prevention Research Funding Appropriations GME funding/teaching health centers Education: H.R. 2028, Resident Education Deferred Interest (REDI) Act, all provisions S. 942, Resident Education Deferred Interest (REDI) Act, all provisions H.R. 2314, Fair Access In Residency (FAIR) Act, provisions to the MATCH, and foreign medical graduates S. 2715, Fair Access In Residency (FAIR) Act, provisions to the MATCH, and foreign medical graduates S. 632, IHS Workforce Parity Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to Graduate Medical Education, and student loans H.R. 3890, Resident Physician Shortage Reduction Act of 2025, all provisions S. 2439, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4681, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions H.R. 6468, Rural Residency Planning and Development Act of 2025, all provisions H.R. 3885, Community Training, Education, and Access for Medical Students (Community TEAMS) Act of 2025, all provisions S. 632, IHS Workforce Parity Act of 2025, all provisions GME funding/teaching health centers National Health Service Corps (NHSC)/loan repayment programs NHSC Scholarship program Health Issues: H.R. 2332, States Handling Access to Reciprocity for Employment (SHARE) Act of 2025, all provisions H.R. 1521, Dental and Optometric Care (DOC) Access Act of 2025, all provisions H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 526, Pharmacy Benefit Manager Transparency Act of 2025, all provisions S. 1767, Physician and Patient Safety Act, all provisions H.R. 2767, Bolstering Research And Innovation Now (BRAIN) Act, all provisions S. 1330, Bolstering Research And Innovation Now (BRAIN) Act, all provisions H.R. 1520, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S. 1782, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S. 3315, Health Care Cybersecurity and Resiliency Act of 2026, all provisions S. 3097, Health Information Privacy Reform Act, all provisions H.R. 4583, Living Donor Protection Act of 2025, all provisions S. 1552, Living Donor Protection Act of 2025, all provisions H.R. 2850, Youth Sports Facilities Act of 2025, all provisions S. 1419, Youth Sports Facilities Act of 2025, all provisions S. 1701, Strategic Teams for Organized Response Mobilization (STORM) Act, all provisions H.R. 4849, Protecting Health Care and Lowering Costs Act of 2025, all provisions H.R. 247, Health Care Affordability Act of 2025, all provisions H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credits S. 3385, Lower Health Care Costs Act, provisions related to the ACA and premium tax credits H.R. 6703, Lower Health Care Premiums for All Americans Act, all provisions H.R. 3492, Protect Childrens Innocence Act, all provisions H.R. 5861, Legacy Act of 2025, provisions related to advanced medical directives S. 3315, Health Care Cybersecurity and Resiliency Act of 2026, all provisions H.R. 7868, Expanding Support for Living Donors Act of 2026, all provisions H.R. 628, Honor Our Living Donors Act, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to artificial intelligence (AI) H.R. 1909, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions S. 3204, Preventive Health Savings Act, all provisions H.R. 7602, State of Mens Health Act, all provisions H.R. 4710, No Surprises Act Enforcement Act, all provisions S. 2420, No Surprises Act Enforcement Act, all provisions H.R. 6294, Childhood Diabetes Reduction Act of 2025, all provisions H.R. 4206, CONNECT for Health Act of 2025, all provisions H.R. 3170, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions Joint resolution of Disapproval on CMS reg Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (Effort to repeal a regulation under the Congressional Review Act) Drafts/The Republic Unifying Meritocratic Performance Advancing Machine Intelligence by Eliminating Regulatory Interstate Chaos Across American Industry Act (TRUMP AMERICA AI) Act Draft/Enhanced Premium Tax Credits extension Drug shortages Gender affirming care Dental plans/The Employee Retirement Income Security Act of 1974 (ERISA) Prior authorization Licensure portability Artificial Intelligence (AI) services/payment AI use in prior authorization Womens health issues Health Insurance Portability and Accountability Act (HIPAA) Pharmacy Benefits Managers AI Deepfake/legislative framework Mental health chatbots/regulatory guardrails Cybersecurity/small physician practices Fuel economy standards/proposed rollback Postpartum hypertension Vaccines Nutrition Menopause education Insurance plans/downcoding Out-of-Network physician payment cut Immigration: H.R. 5283, Healthcare Workforce Resilience Act, all provisions S. 2759, Healthcare Workforce Resilience Act, all provisions H.R. 1585, Conrad State 30 and Physician Access Reauthorization Act, all provisions S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions H.R. 1201, Doctors in our Borders Act, all provisions S. 2650, DOCTORS Act, all provisions H.R.7964, Halt Immigration from Countries with Inadequate Verification Capabilities Act, all provisions H.R. 7961, H-1Bs for Physicians and the Healthcare Workforce Act, all provisions Duration of status for J-1 visa physicians H-1B visa/filing fee/regulatory changes H-1B and J-1 visas/administrative pause Foreign Medical Graduates (FMGs)/pathways to citizenship Proclamation 10998/Physician exemption Indian/Native American Affairs: S. 632, IHS Workforce Parity Act of 2025, all provisions Labor Issues/Antitrust/Workplace: S. 527, Prescription Pricing for the People Act of 2025, all provisions S. 232, Preventing Algorithmic Collusion Act of 2025, all provisions S. 3822, Break Up Big Medicine Act, all provisions Health insurance/competition Consolidation in health care markets Medicare/Medicaid: H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S. 1640, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S, 891, Bipartisan Health Care Act, all provisions H.R. 786, Preserving Patient Access to Accountable Care Act, all provisions S. 1460, Preserving Patient Access to Accountable Care Act, all provisions H.R. 539, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions S. 106, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions H.R. 1317, Improving Care and Access to Nurses (I CAN) Act, all provisions H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions S. 1390, Physician Led and Rural Access to Quality Care Act, all provisions S. 665, Fatal Overdose Reduction Act of 2025, all provisions H.R, 4977, Connected MOM Act, all provisions S. 141, Connected MOM Act, all provisions H.R. 3514, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1816, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1105, No UPCODE Act, all provisions H.R. 5081, Telehealth Modernization Act, all provisions S. 2709, Telehealth Modernization Act, all provisions H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act, provisions related to Medicare payment reform, Medicaid reforms, Alternative Payment Models (APMs) H.R. 6160, Strengthening Medicare for Patients and Providers Act, all provisions H.R. 7520, Efficiency Adjustment Delay Act, all provisions H.R. 7148, Consolidated Appropriations Act, 2026, provisions related to APM bonus extension/incentive payments/qualifying provider revenue thresholds freeze H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to APMs H.R. 8163, To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program, all provisions H.R. 2120, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions S. 1031, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions H.R. 483, Health Care Efficiency Through Flexibility Act, all provisions H.R. 5347, Health Care Efficiency Through Flexibility Act, all provisions H.R. 8129, To amend title XVIII of the Social Security Act to establish a full risk ACO program, all provisions H.R. 1614, To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program, all provisions H.R. 3108, Rural Patient Monitoring (RPM) Access Act, all provisions S. 1535, Rural Patient Monitoring (RPM) Access Act, all provisions H.R. 3164, Ensuring Community Access to Pharmacist Services Act, all provisions H.R. 2725, Affordable Housing Credit Improvement Act of 2025, all provisions H.R. 2757, Medicare Audiology Access Improvement Act of 2025, all provisions S. 1996, Medicare Audiology Access Improvement Act of 2025, all provisions H.R. 3878, RNs for Rural Health Act of 2025, all provisions H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, all provisions H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025, all provisions H.R. 5467, Patient Access to Autoimmune Treatments (PAAT) Act, all provisions H.R. 5940, Seniors Deserve Streamlined Medical Approvals for Timely, Efficient Recovery (SMARTER) Care Act of 2025, all provisions S. 3480, Seniors Deserve Streamlined Medical Approvals for Timely, Efficient Recovery (SMARTER) Care Act of 2025, all provisions H.R. 4002, Patient Access to Higher Quality Health Care Act of 2025, all provisions H.R. 3022, Restoring Rights of Physicians to Own Hospitals Act, all provisions S. 1399, Health Tech Investment Act, all provisions S. 3386, Health Care Freedom for Patients Act of 2025, provisions related to the ACA H.R. 498, Do No Harm in Medicaid Act, all provisions H.R. 4710, No Surprises Act Enforcement Act, all provisions S. 2420, No Surprises Act Enforcement Act, all provisions S. 1692, Radiology Outpatient Ordering Transmission (ROOT) Act, provisions related to imaging appropriate use criteria H.R. 5737, Radiology Outpatient Ordering Transmission (ROOT) Act, provisions related to imaging appropriate use criteria H.R. 3164, Equitable Community Access to Pharmacist Services Act, all provisions S. 2426, Equitable Community Access to Pharmacist Services Act, all provisions S. 3934, Medical Nutrition Therapy Act of 2026, all provisions H.R. 4206, CONNECT for Health Act of 2025, all provisions No Fees for EFTs Act, all provisions Drafts/Chronic Care Management Improvement Act Drafts/Access to Genetic Counselor Services Act Drafts/GOLD CARD Act Drafts/Medicare Advantage Improvement Act Draft/Value in Health Care Act Draft/Medicare Budget Neutrality and MIPS reform Draft/MACRA/MIPS program reform Medicare program: Medicare Economic Index (MEI)/inflationary updates Medicare program: Medicare physician payment/budget neutrality Medicare program: Merit-based Incentive Payment System (MIPS)/reforms and penalties Medicare program: MIPS Value Pathways (MVPs) reform Medicare program: MIPS quality and cost measures Medicare program: G2211 Inherent Complexity Code Medicare program: Alternative Payment Models (APMs) Medicare program: ACO (Accountable Care Organization) REACH Model Medicare program: Long-term Enhanced ACO Design (LEAD) Model Medicare program: ACO/APM flexibilities Medicare program: Prior authorization Medicare program: Wasteful and Inappropriate Service Reduction (WISeR) and Ambulatory Specialty Model Medicare program: Site Neutral Payment Medicare program: AI chatbots/Medicare Advantage preventive screens Medicare program: Coding Medicare program: MEI Update Medicare program: AI services/payment Medicare program: Indirect practice expense Medicare program: Telehealth and Digital Health Medicare program: Medicare Advantage provider networks/physician experience Medicare program: Shared Savings Program Medicare program: Medicare Diabetes Prevention Program Medicare program: Data-Driven Performance Payment System Medicare program: Promoting Interoperability (PI) Program Medicare program: Quality Payment Program Medicare program: Certified electronic health record and PI Medicare program: Advanced APM reporting Medicare program: Public Health Reporting and Data Exchange Medicare program: Provider directories Medicare program: Digital quality measures Medicare program: Aligned Networks and interoperability Medicare program: Health Information Technology/physician burdens Medicare program: Data privacy/cybersecurity Medicare program: Review Choice Demonstration (RCD)/Inpatient Rehabilitation Facility (IRF) Medicare program: Organ transplantation access Medicare program: Prior authorization/Medical billing transition Medicare program: Traditional Medicare/Medicare Advantage enrollment difficulties Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/broad reform Medicare and Medicaid programs: MACRA/physician burdens Medicare and Medicaid programs: Telehealth Medicare and Medicaid programs: Center for Medicare and Medicaid Innovation (CMMI) reforms Medicare and Medicaid programs: CMMI reform/Physician AI use Medicare and Medicaid programs: High-cost disposable supplies/billing codes Medicaid program: Gender affirming care Medicaid program: Work requirements, per capita caps, provider taxes, FMAP changes Medicaid program: Community engagement/medical frailty exemption Taxation/Internal Revenue Code: H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credits S. 3385, Lower Health Care Costs Act, provisions related to the ACA and premium tax credits H.R. 6575, CommonGround for Affordable Health Care Act, provisions related to ACA tax credits H.R. 6501, Bipartisan Health Insurance Affordability Act, provisions related to ACA premium tax credits Draft/Enhanced Premium Tax Credits extension Community preceptors for medical students and residents/National tax credit or deduction Torts: Medical liability insurance Veterans: H.R. 4837, Written Informed Consent Act, all provisions H.R. 3951, Rural Veterans Improved Access to Benefits Act of 2025, all provisions Community care providers/External Provider Scheduling (EPS) program Standardized protocols for identifying veterans in patient populations Shaving waivers

Reported lobbying issue

Budget/Appropriations: H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to Alternative Payment Models (APMs) H.R. 7148, Consolidated Appropriations Act, 2026, provisions related to APM bonus extension/incentive payments/qualifying provider revenue thresholds freeze H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, provisions relating to telehealth, Affordable Care Act (ACA) premium tax credits S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credits S. 3204, Preventive Health Savings Act, all provisions FY 2026 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill, provisions related to Stillbirth Working Groups funding H.R. 1197, PREEMIE Reauthorization Act of 2025, all provisions H.R. 1909, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions Womens health research funding/reproductive health/fertility treatments FY27 Gun Violence Prevention Research Funding Appropriations GME funding/teaching health centers Education: H.R. 2028, Resident Education Deferred Interest (REDI) Act, all provisions S. 942, Resident Education Deferred Interest (REDI) Act, all provisions H.R. 2314, Fair Access In Residency (FAIR) Act, provisions to the MATCH, and foreign medical graduates S. 2715, Fair Access In Residency (FAIR) Act, provisions to the MATCH, and foreign medical graduates S. 632, IHS Workforce Parity Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to Graduate Medical Education, and student loans H.R. 3890, Resident Physician Shortage Reduction Act of 2025, all provisions S. 2439, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4681, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions H.R. 6468, Rural Residency Planning and Development Act of 2025, all provisions H.R. 3885, Community Training, Education, and Access for Medical Students (Community TEAMS) Act of 2025, all provisions S. 632, IHS Workforce Parity Act of 2025, all provisions GME funding/teaching health centers National Health Service Corps (NHSC)/loan repayment programs NHSC Scholarship program Health Issues: H.R. 2332, States Handling Access to Reciprocity for Employment (SHARE) Act of 2025, all provisions H.R. 1521, Dental and Optometric Care (DOC) Access Act of 2025, all provisions H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 526, Pharmacy Benefit Manager Transparency Act of 2025, all provisions S. 1767, Physician and Patient Safety Act, all provisions H.R. 2767, Bolstering Research And Innovation Now (BRAIN) Act, all provisions S. 1330, Bolstering Research And Innovation Now (BRAIN) Act, all provisions H.R. 1520, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S. 1782, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S. 3315, Health Care Cybersecurity and Resiliency Act of 2026, all provisions S. 3097, Health Information Privacy Reform Act, all provisions H.R. 4583, Living Donor Protection Act of 2025, all provisions S. 1552, Living Donor Protection Act of 2025, all provisions H.R. 2850, Youth Sports Facilities Act of 2025, all provisions S. 1419, Youth Sports Facilities Act of 2025, all provisions S. 1701, Strategic Teams for Organized Response Mobilization (STORM) Act, all provisions H.R. 4849, Protecting Health Care and Lowering Costs Act of 2025, all provisions H.R. 247, Health Care Affordability Act of 2025, all provisions H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credits S. 3385, Lower Health Care Costs Act, provisions related to the ACA and premium tax credits H.R. 6703, Lower Health Care Premiums for All Americans Act, all provisions H.R. 3492, Protect Childrens Innocence Act, all provisions H.R. 5861, Legacy Act of 2025, provisions related to advanced medical directives S. 3315, Health Care Cybersecurity and Resiliency Act of 2026, all provisions H.R. 7868, Expanding Support for Living Donors Act of 2026, all provisions H.R. 628, Honor Our Living Donors Act, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to artificial intelligence (AI) H.R. 1909, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025, all provisions S. 3204, Preventive Health Savings Act, all provisions H.R. 7602, State of Mens Health Act, all provisions H.R. 4710, No Surprises Act Enforcement Act, all provisions S. 2420, No Surprises Act Enforcement Act, all provisions H.R. 6294, Childhood Diabetes Reduction Act of 2025, all provisions H.R. 4206, CONNECT for Health Act of 2025, all provisions H.R. 3170, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions Joint resolution of Disapproval on CMS reg Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (Effort to repeal a regulation under the Congressional Review Act) Drafts/The Republic Unifying Meritocratic Performance Advancing Machine Intelligence by Eliminating Regulatory Interstate Chaos Across American Industry Act (TRUMP AMERICA AI) Act Draft/Enhanced Premium Tax Credits extension Drug shortages Gender affirming care Dental plans/The Employee Retirement Income Security Act of 1974 (ERISA) Prior authorization Licensure portability Artificial Intelligence (AI) services/payment AI use in prior authorization Womens health issues Health Insurance Portability and Accountability Act (HIPAA) Pharmacy Benefits Managers AI Deepfake/legislative framework Mental health chatbots/regulatory guardrails Cybersecurity/small physician practices Fuel economy standards/proposed rollback Postpartum hypertension Vaccines Nutrition Menopause education Insurance plans/downcoding Out-of-Network physician payment cut Immigration: H.R. 5283, Healthcare Workforce Resilience Act, all provisions S. 2759, Healthcare Workforce Resilience Act, all provisions H.R. 1585, Conrad State 30 and Physician Access Reauthorization Act, all provisions S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions H.R. 1201, Doctors in our Borders Act, all provisions S. 2650, DOCTORS Act, all provisions H.R.7964, Halt Immigration from Countries with Inadequate Verification Capabilities Act, all provisions H.R. 7961, H-1Bs for Physicians and the Healthcare Workforce Act, all provisions Duration of status for J-1 visa physicians H-1B visa/filing fee/regulatory changes H-1B and J-1 visas/administrative pause Foreign Medical Graduates (FMGs)/pathways to citizenship Proclamation 10998/Physician exemption Indian/Native American Affairs: S. 632, IHS Workforce Parity Act of 2025, all provisions Labor Issues/Antitrust/Workplace: S. 527, Prescription Pricing for the People Act of 2025, all provisions S. 232, Preventing Algorithmic Collusion Act of 2025, all provisions S. 3822, Break Up Big Medicine Act, all provisions Health insurance/competition Consolidation in health care markets Medicare/Medicaid: H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S. 1640, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S, 891, Bipartisan Health Care Act, all provisions H.R. 786, Preserving Patient Access to Accountable Care Act, all provisions S. 1460, Preserving Patient Access to Accountable Care Act, all provisions H.R. 539, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions S. 106, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions H.R. 1317, Improving Care and Access to Nurses (I CAN) Act, all provisions H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions S. 1390, Physician Led and Rural Access to Quality Care Act, all provisions S. 665, Fatal Overdose Reduction Act of 2025, all provisions H.R, 4977, Connected MOM Act, all provisions S. 141, Connected MOM Act, all provisions H.R. 3514, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1816, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1105, No UPCODE Act, all provisions H.R. 5081, Telehealth Modernization Act, all provisions S. 2709, Telehealth Modernization Act, all provisions H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act, provisions related to Medicare payment reform, Medicaid reforms, Alternative Payment Models (APMs) H.R. 6160, Strengthening Medicare for Patients and Providers Act, all provisions H.R. 7520, Efficiency Adjustment Delay Act, all provisions H.R. 7148, Consolidated Appropriations Act, 2026, provisions related to APM bonus extension/incentive payments/qualifying provider revenue thresholds freeze H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to APMs H.R. 8163, To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program, all provisions H.R. 2120, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions S. 1031, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions H.R. 483, Health Care Efficiency Through Flexibility Act, all provisions H.R. 5347, Health Care Efficiency Through Flexibility Act, all provisions H.R. 8129, To amend title XVIII of the Social Security Act to establish a full risk ACO program, all provisions H.R. 1614, To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program, all provisions H.R. 3108, Rural Patient Monitoring (RPM) Access Act, all provisions S. 1535, Rural Patient Monitoring (RPM) Access Act, all provisions H.R. 3164, Ensuring Community Access to Pharmacist Services Act, all provisions H.R. 2725, Affordable Housing Credit Improvement Act of 2025, all provisions H.R. 2757, Medicare Audiology Access Improvement Act of 2025, all provisions S. 1996, Medicare Audiology Access Improvement Act of 2025, all provisions H.R. 3878, RNs for Rural Health Act of 2025, all provisions H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, all provisions H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025, all provisions H.R. 5467, Patient Access to Autoimmune Treatments (PAAT) Act, all provisions H.R. 5940, Seniors Deserve Streamlined Medical Approvals for Timely, Efficient Recovery (SMARTER) Care Act of 2025, all provisions S. 3480, Seniors Deserve Streamlined Medical Approvals for Timely, Efficient Recovery (SMARTER) Care Act of 2025, all provisions H.R. 4002, Patient Access to Higher Quality Health Care Act of 2025, all provisions H.R. 3022, Restoring Rights of Physicians to Own Hospitals Act, all provisions S. 1399, Health Tech Investment Act, all provisions S. 3386, Health Care Freedom for Patients Act of 2025, provisions related to the ACA H.R. 498, Do No Harm in Medicaid Act, all provisions H.R. 4710, No Surprises Act Enforcement Act, all provisions S. 2420, No Surprises Act Enforcement Act, all provisions S. 1692, Radiology Outpatient Ordering Transmission (ROOT) Act, provisions related to imaging appropriate use criteria H.R. 5737, Radiology Outpatient Ordering Transmission (ROOT) Act, provisions related to imaging appropriate use criteria H.R. 3164, Equitable Community Access to Pharmacist Services Act, all provisions S. 2426, Equitable Community Access to Pharmacist Services Act, all provisions S. 3934, Medical Nutrition Therapy Act of 2026, all provisions H.R. 4206, CONNECT for Health Act of 2025, all provisions No Fees for EFTs Act, all provisions Drafts/Chronic Care Management Improvement Act Drafts/Access to Genetic Counselor Services Act Drafts/GOLD CARD Act Drafts/Medicare Advantage Improvement Act Draft/Value in Health Care Act Draft/Medicare Budget Neutrality and MIPS reform Draft/MACRA/MIPS program reform Medicare program: Medicare Economic Index (MEI)/inflationary updates Medicare program: Medicare physician payment/budget neutrality Medicare program: Merit-based Incentive Payment System (MIPS)/reforms and penalties Medicare program: MIPS Value Pathways (MVPs) reform Medicare program: MIPS quality and cost measures Medicare program: G2211 Inherent Complexity Code Medicare program: Alternative Payment Models (APMs) Medicare program: ACO (Accountable Care Organization) REACH Model Medicare program: Long-term Enhanced ACO Design (LEAD) Model Medicare program: ACO/APM flexibilities Medicare program: Prior authorization Medicare program: Wasteful and Inappropriate Service Reduction (WISeR) and Ambulatory Specialty Model Medicare program: Site Neutral Payment Medicare program: AI chatbots/Medicare Advantage preventive screens Medicare program: Coding Medicare program: MEI Update Medicare program: AI services/payment Medicare program: Indirect practice expense Medicare program: Telehealth and Digital Health Medicare program: Medicare Advantage provider networks/physician experience Medicare program: Shared Savings Program Medicare program: Medicare Diabetes Prevention Program Medicare program: Data-Driven Performance Payment System Medicare program: Promoting Interoperability (PI) Program Medicare program: Quality Payment Program Medicare program: Certified electronic health record and PI Medicare program: Advanced APM reporting Medicare program: Public Health Reporting and Data Exchange Medicare program: Provider directories Medicare program: Digital quality measures Medicare program: Aligned Networks and interoperability Medicare program: Health Information Technology/physician burdens Medicare program: Data privacy/cybersecurity Medicare program: Review Choice Demonstration (RCD)/Inpatient Rehabilitation Facility (IRF) Medicare program: Organ transplantation access Medicare program: Prior authorization/Medical billing transition Medicare program: Traditional Medicare/Medicare Advantage enrollment difficulties Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/broad reform Medicare and Medicaid programs: MACRA/physician burdens Medicare and Medicaid programs: Telehealth Medicare and Medicaid programs: Center for Medicare and Medicaid Innovation (CMMI) reforms Medicare and Medicaid programs: CMMI reform/Physician AI use Medicare and Medicaid programs: High-cost disposable supplies/billing codes Medicaid program: Gender affirming care Medicaid program: Work requirements, per capita caps, provider taxes, FMAP changes Medicaid program: Community engagement/medical frailty exemption Taxation/Internal Revenue Code: H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credits S. 3385, Lower Health Care Costs Act, provisions related to the ACA and premium tax credits H.R. 6575, CommonGround for Affordable Health Care Act, provisions related to ACA tax credits H.R. 6501, Bipartisan Health Insurance Affordability Act, provisions related to ACA premium tax credits Draft/Enhanced Premium Tax Credits extension Community preceptors for medical students and residents/National tax credit or deduction Torts: Medical liability insurance Veterans: H.R. 4837, Written Informed Consent Act, all provisions H.R. 3951, Rural Veterans Improved Access to Benefits Act of 2025, all provisions Community care providers/External Provider Scheduling (EPS) program Standardized protocols for identifying veterans in patient populations Shaving waivers

Reported lobbying issue

Budget/Appropriations: Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2027 Labor-HHS appropriations process. Veterans: Issues pertaining to veterans' access to proton therapy. Medicare/Medicaid: Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment. Health Issues: Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation. Health Issues: H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Mikaela Naylon Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. Budget/Appropriations: FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP).

Reported lobbying issue

Health Issues: FY2026 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Policy initiatives designed to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations Medicare/Medicaid: Oppose CMS's "efficiency adjustment" Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 2120 and S. 1031, a bill to modernize radiation oncology reimbursement - The Radiation Oncology Case Rate Value Based Program Act of 2025 Support for H.R. 879, to fix Medicare Physician Fee Schedule's physician payment reimbursement cuts Support H.R.3514, S.1816, the Improving Seniors' Timely Access to Care Act Support for H.R. 6160, Strengthening Medicare for Patients and Providers Act Homeland Security: U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC) Budget/Appropriations: Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for FY 2026 and FY2027 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding Support for report language encouraging NIH to support research into functional radiation medicine

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640: Medicare Patient Access and Practice Stabilization Act of 2025 - The bill extends Medicare payment adjustment timelines to 2025 and introduces an 8.51 percent adjustment for services between June 1, 2025, and January 1, 2026, to support healthcare providers in adapting to payment changes. S. 1460: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H. 879: Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). H.R. 786: Preserving Patient Access to Accountable Care Act. Incentivizing the transition to value-based care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation. Health Issues: H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. Budget/Appropriations: FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP).

Reported lobbying issue

Budget/Appropriations: H.R. 1, One Big Beautiful Bill Act (PL 119-21), provisions relating to Graduate Medical Education, Medicare Physician Payment Reform, Medicaid Reform (work requirements, per capita caps, provider taxes, and FMAP changes), Alternative Payment Models, Artificial Intelligence (AI), ACA Marketplace H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, provisions relating to Medicare Physician Payment Reform, Affordable Care Act (ACA) premium tax credit H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions relating to APMs S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credit S. 3204, Preventive Health Savings Act, all provisions FY2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, provisions related to Office on Smoking and Health funding levels; funding for stillbirth working groups Education: H.R. 768, Need-Based Educational Aid Act of 2001, all provisions H.R. 2028, Resident Education Deferred Interest (REDI) Act, all provisions S. 942, Resident Education Deferred Interest (REDI) Act, all provisions H.R. 2314, Fair Access In Residency (FAIR) Act, all provisions S. 2715, Fair Access In Residency (FAIR) Act, all provisions S. 632, IHS Workforce Parity Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act (PL 119-21), provisions relating to Graduate Medical Education, and student loans H.R. 3890, Resident Physician Shortage Reduction Act of 2025, all provisions S. 2439, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 681, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions Health Issues: S. 891, Bipartisan Health Care Act, all provisions H.R. 2332, States Handling Access to Reciprocity for Employment (SHARE) Act of 2025, all provisions H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 526, Pharmacy Benefit Manager Transparency Act of 2025, all provisions S. 1767, Physician and Patient Safety Act, all provisions H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, provisions relating to scope of practice S. 232, Preventing Algorithmic Collusion Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act (PL 119-21), provisions relating to ACA Marketplace H.R. 4849, Protecting Health Care and Lowering Costs Act of 2025, all provisions H.R. 247, Health Care Affordability Act of 2025, all provisions S. 3385, Lower Health Care Costs Act, all provisions H.R. 6703, Lower Health Care Premiums for All Americans Act, all provisions S. 1701, Strategic Teams for Organized Response Mobilization (STORM) Act, all provisions H.R. 3492, Protect Childrens Innocence Act, all provisions H.R. 5861, Legacy Act of 2025, all provisions H.R. 4313, Hospital Inpatient Services Modernization Act, all provisions S. 2237, Hospital Inpatient Services Modernization Act, all provisions S. 3315, Health Care Cybersecurity and Resiliency Act of 2025, all provisions S. 3097, Health Information Privacy Reform Act, all provisions H.R. 5469, Stillbirth Health Improvement and Education (SHINE) for Autumn Act of 2025, all provisions S. 2858, Stillbirth Health Improvement and Education (SHINE) for Autumn Act of 2025, all provisions S.J.Res.84, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Market Integrity and Affordability,/Congressional Review Act repeal effort Drug shortages Prior Authorization Sleep Apnea/H3 Standard Maternal health Licensure portability issues Data privacy/cybersecurity Toxic Substances Control Act/chemical risk evaluation Health Insurance Portability and Accountability Act (HIPAA)/Electronic health records ACA/Enhanced Advanced Premium Tax Credit 2026-2030 dietary guidelines Downcoding by insurance plans Drug and medical device/recalls Medical products/tariffs Artificial Intelligence Immigration: H.R. 5283, Healthcare Workforce Resilience Act, all provisions S. 2759, Healthcare Workforce Resilience Act, all provisions H.R. 1585, Conrad State 30 and Physician Access Reauthorization Act, all provisions S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions H.R. 1201, Doctors in our Borders Act, all provisions S. 2650, DOCTORS Act, all provisions Duration of status for J-1 visa physicians H-1B visa/filing fees International Medical Graduates (IMGs)/Alternative Pathways Public charge Labor Issues/Antitrust/Workplace: S. 527, Prescription Pricing for the People Act of 2025, all provisions Medicare/Medicaid: H.R. 539, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions S. 106, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions H.R. 1317, Improving Care and Access to Nurses (I CAN) Act, all provisions H.R. 1521, Dental and Optometric Care (DOC) Access Act of 2025, all provisions H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions S. 1390, Physician Led and Rural Access to Quality Care Act, all provisions S. 665, Fatal Overdose Reduction Act of 2025, all provisions H.R. 4977, Connected MOM Act, all provisions H.R. 1, One Big Beautiful Bill Act (PL 119-21), provisions relating to Graduate Medical Education, Medicare Physician Payment Reform, Medicaid Reform (work requirements, per capita caps, provider taxes, and FMAP changes), Alternative Payment Models (APMs), Artificial Intelligence (AI), and Medicaid biannual redetermination requirements S. 141, Connected MOM Act, all provisions H.R. 3514, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1816, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1105, No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (No UPCODE) Act, all provisions H.R. 5081, Telehealth Modernization Act, all provisions S. 2709, Telehealth Modernization Act, all provisions H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S. 1640, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions H.R. 6160, Strengthening Medicare for Patients and Providers Act, all provisions H.R. 786, Preserving Patient Access to Accountable Care Act, all provisions S. 1460, Preserving Patient Access to Accountable Care Act, all provisions H.R. 2120, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions S. 1031, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions relating to APMs H.R. 483, Health Care Efficiency Through Flexibility Act, provisions relating to APMs H.R. 3890, Resident Physician Shortage Reduction Act of 2025, all provisions S. 2439, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4206, CONNECT for Health Act of 2025, all provisions S. 1261, CONNECT for Health Act of 2025, all provisions H.R. 1614, To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program, all provisions H.R. 3108, Rural Patient Monitoring (RPM) Access Act, all provisions S. 1535, Rural Patient Monitoring (RPM) Access Act, all provisions H.R. 3164, Ensuring Community Access to Pharmacist Services (ECAPS) Act, all provisions S. 2426, Equitable Community Access to Pharmacist Services (ECAPS) Act, all provisions H.R. 2757, Medicare Audiology Access Improvement Act of 2025, all provisions S. 1996, Medicare Audiology Access Improvement Act of 2025, all provisions H.R. 3878, RNs for Rural Health Act of 2025, all provisions H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, all provisions H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025, all provisions H.R. 5467, Patient Access to Autoimmune Treatments (PAAT) Act, all provisions H.R. 5940, Seniors Deserve SMARTER Care Act of 2025, all provisions S. 3480, Seniors Deserve SMARTER Care Act of 2025, all provisions H.R. 4002, Patient Access to Higher Quality Health Care Act of 2025, all provisions H.R. 3022, Restoring Rights of Physicians to Own Hospitals Act, all provisions S. 1399, Health Tech Investment Act, all provisions H.R. 4710, No Surprises Act Enforcement Act, all provisions S. 2420, No Surprises Act Enforcement Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credit S.J.Res.84, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Market Integrity and Affordability,/Congressional Review Act repeal effort S. 3386, Health Care Freedom for Patients Act of 2025, provisions related to ACA premium tax credit H.R. 6575, CommonGround for Affordable Health Care Act, provisions related to ACA premium tax credit H.R. 6501, Bipartisan Health Insurance Affordability Act, provisions related to ACA premium tax credit H.R. 5737, Radiology Outpatient Ordering Transmission (ROOT) Act, all provisions S. 1692, Radiology Outpatient Ordering Transmission (ROOT) Act, all provisions H.R. 5813, Womens Health and Cancer Rights Modernization Act of 2025, all provisions H.R. 5347, Health Care Efficiency Through Flexibility Act, all provisions H.R. 5269, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025, all provisions S. 2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025, all provisions Access to Genetic Counselor Services Act/draft GOLD CARD Act/drafts Medicare Access to Radiology Care (MARCA) Act/drafts Data-Driven Payment Performance System (DPPS) Act/draft Value in Health Care Act/draft Legislation to reform the MACRA and MIPS Programs/draft Medicare program: Medicare Economic Index (MEI)/Physician inflationary updates Medicare program: Medicare Physician Payment System/Budget Neutrality reforms Medicare program: MEDPAC/physician practice 2027 payment update/full MEI update recommendation Medicare program: Merit-Based Incentive Payment System (MIPS)/reforms/penalties/replacement proposal Medicare program: CY 2026 Medicare Physician Fee Schedule/implementation phase-in/indirect practice expense Medicare program: APMs/bonuses/incentive payments Medicare program: G2211 Inherent Complexity Code Medicare program: Private practice physician issues/benchmark survey Medicare program: Center for Medicare & Medicaid Innovation (CMMI) reforms Medicare program: Payer and EHR developers/proprietary technology and electronic prior authorizations Medicare program: Prior Authorization/AI Medicare program: Medicare Advantage/prior authorization Medicare program: Site neutral payment Medicare program: Coding Medicare program: Medicare Advantage/preventive screens/AI Chatbots Medicare program: AI services/payment Medicare program: Diabetes Prevention Program Medicare program: Promoting Interoperability (PI) Program Medicare program: Quality Payment Program Medicare program: HIPAA/Electronic health records Medicare program: Certified electronic health record technology and PI Medicare program: Medicare Shared Savings Program/Advanced APM reporting Medicare program: Public Health Reporting and Data Exchange Medicare program: Value-based care delivery Medicare program: Telehealth/digital health/budget neutrality Medicare program: Medicare Telehealth waiver extension Medicare program: Wasteful and Inappropriate Service Reduction (WISER) payment model Medicare program: Modifier 25/appropriate use Medicare program: Provider directories Medicare program: ACO/MIPS/skin substitutes/clinicians increased spending Medicare program: ACO/APM flexibilities Medicare program: Local Coverage Determination/peripheral nerve blocks/chronic pain procedures Medicare program: Data privacy/cybersecurity Medicare program: ACA/Enhanced tax credit extension Medicare program: Digital health and wearables Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/broad reform Medicare and Medicaid programs: MACRA/physician burdens Medicare and Medicaid programs: Health IT/physician burdens Taxation/Internal Revenue Code: S. 3385, Lower Health Care Costs Act, provisions relating to healthcare premium tax credit H.R. 6575, CommonGround for Affordable Health Care Act, provisions relating to ACA premium tax credit H.R. 6501, Bipartisan Health Insurance Affordability Act, provisions related to ACA premium tax credit H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to ACA premium tax credit S.J.Res.84, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Market Integrity and Affordability,/Congressional Review Act repeal effort S. 3386, Health Care Freedom for Patients Act of 2025, provisions related to ACA premium tax credit ACA/Enhanced tax credit extension Tobacco: FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, provisions related to Office on Smoking and Health funding levels Veterans: H.R. 4837, Written Informed Consent Act, all provisions H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, provisions related to hospital-at-home H.R. 3951, Rural Veterans Improved Access to Benefits Act of 2025, all provisions

Reported lobbying issue

Health Issues: FY2026 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Policy initiatives designed to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations Medicare/Medicaid: Oppose CMS's "efficiency adjustment" Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 2120 and S. 1031, a bill to modernize radiation oncology reimbursement - The Radiation Oncology Case Rate Value Based Program Act of 2025 Support for H.R. 879, to fix Medicare Physician Fee Schedule's physician payment reimbursement cuts in 2025 Support H.R.3514, S.1816, the Improving Seniors' Timely Access to Care Act Support for H.R. 6160, Strengthening Medicare for Patients and Providers Act Homeland Security: U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC) Budget/Appropriations: Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for FY 2025 and FY 2026 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding

Reported lobbying issue

Health Issues: H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Medicare/Medicaid: H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness Pharmacy: H.R. 3164, Ensuring Community Access to Pharmacist Services Act Manufacturing: H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains

Reported lobbying issue

Health Issues: H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Medicare/Medicaid: H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness. Pharmacy: H.R. 3164, Ensuring Community Access to Pharmacist Services Act Manufacturing: H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains

Reported lobbying issue

Medicare/Medicaid: Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment. Health Issues: Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act. Budget/Appropriations: Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2026 Labor-HHS appropriations process. Veterans: Issues pertaining to veterans' access to proton therapy.